Respecting the technical, delivering the practical

Our expert team will be at ISPOR Annual Montreal, Canada in May 2025. ISPOR is the leading global conference for Health Economics and Outcomes Research and the best place to discuss and disseminate the latest trends in healthcare.

Find out more

Welcome to price transparency with RFP Builder

By matching project requirements, the RFP Builder provides custom quotes, ensuring a perfect alignment with project needs without even having to speak to anyone at FIECON!

Explore pricing

Everything you always wanted to know about JCA

What is JCA? Is my product eligible? The Joint Clinical Assessment (JCA) for oncology, haematology, and ATMPs will be eligible for assessment from January 12th, 2025 with two significant updates this month.

FIECON's Social Responsibility report

Understand our initiatives, milestones, and the substantial progress we have made towards our 2030 goals, including becoming B Corporation® certified and a certified Great Place To Work®.

Key services

We are committed to to supporting the commercialisation of products that make a difference in people’s lives. We work across a product’s lifecycle, to support pharma, med tech and biotech companies around the world.

Outcomes Research

Our team provide unequalled accuracy and quality whilst delivering all aspects of systematic reviews, meta-analyses and patient-level data analyses.

Economic Modelling

We develop a range of robust health economic models that meet the commercial needs of our clients from simple Markov models to complex discrete event simulations.

Health Technology Assessment

We have extensive experience delivering successful HTA submissions in the UK and across the globe.

Value Communication

At FIECON, we understand the value of clear and concise writing, underpinned by robust evidence. We effectively communicate the value of our clients' products in a clear, logical and impactful manner; from global value dossiers to external scientific publications.

Pricing & Reimbursement

We partner with our clients to develop strategies for global pricing and reimbursement, harnessing our extensive KOL and payer network.

Real World Evidence

Our team offers comprehensive real world evidence (RWE) services, including the development of tailored RWE strategies and conducting evidence gap analyses.

Digital Innovation for Strategic Success

At FIECON, we use digital solutions, advanced technology, and AI to enhance the quality of our health economics and market access strategies. By automating processes and improving data analysis, we deliver precise, tailored solutions that optimize product commercialization and ensure strategic success.

FIECON exceeds my expectations by genuinely trying to achieve the best outcomes for our company. Their flexibility to adapt to unexpected changes and apply technical rigour, while respecting the commercial focus of the company is unparalleled. We see FIECON as part of our extended team.”

Senior Market Access Manager, Mid-sized Pharma

It was brilliantly smart and very well explained. It seems obvious now but that is what genius is, making complex things appear simple.”

Associate Director, Mid-sized Pharma

FIECON are my go to trusted partner. The team deliver high-quality work to timeline, every time. But more than this, FIECON has worked as part of our team, working towards achieving the best possible outcome by providing high level strategic input and challenge during our discussions.”

Market Access Director, Small Biotech

FIECON’s highly skilled expert team helped us to successfully tackle a number of tough pricing and access challenges. Apart from their flawless technical expertise, we have a reliable thought partner to pressure test new ideas and strategies that have a broader relevance than purely health economic aspects.”

Disease Area Director, Big Pharma

The pricing and market access research was a high quality work project, which included detailed information to define the overall and country strategy while the gap analysis was instrumental in the next steps preparation. ”

Executive Director, Biotech

FIECON’s strategic approach to problem solving is a breath of fresh air. We highly value their HTA knowledge and expertise, and they consistently deliver the best solution for us.”

Value Demonstration & Access Lead, Big Pharma

It is a pleasure to work with FIECON. The team are passionate about what they do and it really shows in their high-quality, creative solutions. Working with FIECON gives your projects the highest chance of success.”

Senior Vice President, Small Biotech

FIECON’s team is highly experienced, commercially focused, responsive and flexible. A particular strength I highlight is that FIECON’s team becomes a true partner with all company functions that they interact with. ”

Executive Director, Biotech

Keeping up to date

Why Saudi Arabia is the next key market for your Pharma Expansion

In this informative conversation, Lavni Varyani from Pharma BP discusses the evolving HTA process in Saudi Arabia. As a local expertise, Lavni explains how pharmaceutical companies can strategically engage with the market to navigate the upcoming HTA changes from both local and global perspectives.

What does the JCA rollout mean for pharma companies?

In this insightful discussion, Timm Volmer, SmartStep shares his insights on the JCA rollout, Germany's influence in shaping JCA methodology, and how pharmaceutical companies can effectively prepare for the upcoming JCA changes from both local and global perspectives.‍

Meet ISPOR Poster Author : Dhanveer Sandhu

FIECON Associate, Dhanveer Singh Sandhu, shared insights for his co-authored research poster presented at ISPOR Europe 2024, titled "Precedents in decision-making for Highly Specialized Technologies appraised by NICE: key takeaways and recommendations".

Get in touch

Get a completely free, no-obligation opportunity to discuss your needs and see how we can boost your business.

Brainstorm solutions to key challenges with experienced team
Validate your strategy and value evidence
Learn more about FIECON’s products and key areas of expertise and discuss opportunities for collaboration

Thank you!

We received your details. Someone from our team will contact you soon.

Oops!

Something went wrong while submitting the form.

Respecting the technical, delivering the practical

Welcome to price transparency with RFP Builder

Everything you always wanted to know about JCA

FIECON's Social Responsibility report

Key services

Outcomes Research

Economic Modelling

Health Technology Assessment

Value Communication

Pricing & Reimbursement

Real World Evidence

Digital Innovation for Strategic Success

Technology

Digital solutions

Private AI Platform

Keeping up to date

Why Saudi Arabia is the next key market for your Pharma Expansion

What does the JCA rollout mean for pharma companies?

Meet ISPOR Poster Author : Dhanveer Sandhu

Get in touch

Your contact details

Thank you!

Oops!

Thank you for your subscription!

Oops...